Search

everythinglearnresearchcommunity

for

Search:↓

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Tofacitinib may help hair regrowth in familial alopecia areata with immune issues, but more research is needed.

Baricitinib successfully treated severe hair loss.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Newly made nicotinamide compounds could potentially treat cancer.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Ablative fractional laser treatment nearly matches the gene reduction effects of topical vismodegib in skin cancer.

JAK inhibitors show promise for treating skin conditions like eczema, hair loss, and psoriasis.

Continued ritlecitinib treatment helps sustain hair regrowth in alopecia areata patients.

Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

Ritlecitinib works well and is safe for treating alopecia areata.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Compound N4 effectively kills breast cancer cells and compounds N2 and N3 have strong antibacterial and antifungal properties.

Tofacitinib helped regrow hair in a patient with severe hair loss and improved their quality of life without side effects.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.